Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Jan

Showing results (211-220 of 255) with videos related to

Pageof 26
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 5, 2020
Surveillance of Clinically Complete Responders Using Serial <sup>18</sup>F-FDG PET/CT Scans in Patients with Esophageal Cancer After Neoadjuvant ChemoradiotherapyMaria J Valkema, Berend J van der Wilk, Ben M Eyck, et al.
The British Journal of Surgery|February 12, 2025
Detecting residual disease after neoadjuvant chemoradiotherapy for oesophageal squamous cell carcinoma: The prospective multicentre preSINO trialYang Yang, Zhichao Liu, Ian Wong, et al.
The British Journal of Surgery|November 9, 2021
Preferences for active surveillance or standard oesophagectomy: discrete-choice experimentBerend J van der Wilk, Inge Spronk, Bo J Noordman, et al.
JMIR Research Protocols|June 30, 2015
Accuracy of Detecting Residual Disease After Cross Neoadjuvant Chemoradiotherapy for Esophageal Cancer (preSANO Trial): Rationale and ProtocolBo Jan Noordman, Joel Shapiro, Manon Cw Spaander, et al.
Annals of Surgery|March 29, 2017
Impact of Surgical Approach on Long-term Survival in Esophageal Adenocarcinoma Patients With or Without Neoadjuvant ChemoradiotherapyBo Jan Noordman, David van Klaveren, Mark I van Berge Henegouwen, et al.
Endoscopy|December 10, 2019
Endoscopic ultrasound and fine-needle aspiration for the detection of residual nodal disease after neoadjuvant chemoradiotherapy for esophageal cancerRuben D van der Bogt, Berend J van der Wilk, Jan-Werner Poley, et al.
Cell Reports. Medicine|September 6, 2025
ctDNA detects residual disease after neoadjuvant chemoradiotherapy and guides adjuvant therapy in esophageal squamous cell carcinomaZhichao Liu, Guoqiang Wang, Yang Yang, et al.
Health Science Reports|December 19, 2023
Developing an e-learning tool for clinicians to take patient preferences into account in esophageal cancer treatment decision-makingMerel Hermus, Berend J van der Wilk, Jan Willem T Dekker, et al.
The British Journal of Surgery|August 29, 2022
Pathological response to neoadjuvant chemoradiotherapy for oesophageal squamous cell carcinoma: multicentre East Asian and Dutch database comparisonBen M Eyck, Xing Gao, Yang Yang, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|April 15, 2000
Mutation analysis of 3 genes in patients with Leber congenital amaurosisA J Lotery, P Namperumalsamy, S G Jacobson, et al.
Pageof 26

Showing results (211-220 of 255) with videos related to

Sort By:
Pageof 26
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 5, 2020
Surveillance of Clinically Complete Responders Using Serial <sup>18</sup>F-FDG PET/CT Scans in Patients with Esophageal Cancer After Neoadjuvant ChemoradiotherapyMaria J Valkema, Berend J van der Wilk, Ben M Eyck, et al.
The British Journal of Surgery|February 12, 2025
Detecting residual disease after neoadjuvant chemoradiotherapy for oesophageal squamous cell carcinoma: The prospective multicentre preSINO trialYang Yang, Zhichao Liu, Ian Wong, et al.
The British Journal of Surgery|November 9, 2021
Preferences for active surveillance or standard oesophagectomy: discrete-choice experimentBerend J van der Wilk, Inge Spronk, Bo J Noordman, et al.
JMIR Research Protocols|June 30, 2015
Accuracy of Detecting Residual Disease After Cross Neoadjuvant Chemoradiotherapy for Esophageal Cancer (preSANO Trial): Rationale and ProtocolBo Jan Noordman, Joel Shapiro, Manon Cw Spaander, et al.
Annals of Surgery|March 29, 2017
Impact of Surgical Approach on Long-term Survival in Esophageal Adenocarcinoma Patients With or Without Neoadjuvant ChemoradiotherapyBo Jan Noordman, David van Klaveren, Mark I van Berge Henegouwen, et al.
Endoscopy|December 10, 2019
Endoscopic ultrasound and fine-needle aspiration for the detection of residual nodal disease after neoadjuvant chemoradiotherapy for esophageal cancerRuben D van der Bogt, Berend J van der Wilk, Jan-Werner Poley, et al.
Cell Reports. Medicine|September 6, 2025
ctDNA detects residual disease after neoadjuvant chemoradiotherapy and guides adjuvant therapy in esophageal squamous cell carcinomaZhichao Liu, Guoqiang Wang, Yang Yang, et al.
Health Science Reports|December 19, 2023
Developing an e-learning tool for clinicians to take patient preferences into account in esophageal cancer treatment decision-makingMerel Hermus, Berend J van der Wilk, Jan Willem T Dekker, et al.
The British Journal of Surgery|August 29, 2022
Pathological response to neoadjuvant chemoradiotherapy for oesophageal squamous cell carcinoma: multicentre East Asian and Dutch database comparisonBen M Eyck, Xing Gao, Yang Yang, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|April 15, 2000
Mutation analysis of 3 genes in patients with Leber congenital amaurosisA J Lotery, P Namperumalsamy, S G Jacobson, et al.
Pageof 26